Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06900179

The Effectiveness of Augmented Reality Facilitated Education in Promoting Care Management of Malignant Fungating Wounds Among Oncology Nurses

Malignant fungating wounds (MFWs) affect 5-14% of patients with advanced cancer, making them a common complication in this population. Characterized by symptoms such as foul odor, heavy exudate, bleeding, moderate to severe pain, and infection, MFWs cause significant physical discomfort and pose life-threatening risks while also leading to profound psychosocial issues, including shame and social isolation. These factors severely impact patients' quality of life, with half of those diagnosed surviving only six months on average.

However, clinical nursing staff often lack adequate knowledge and skills in managing MFWs, with an average accuracy rate of just 56.5%. Notable deficiencies exist in areas such as wound disinfection, odor control, and wound assessment, directly affecting the quality of patient care and highlighting an urgent need for specialized MFW training. Traditional MFW education often lacks real-life clinical scenarios and hands-on practice, resulting in a gap between learning and application and leaving learners ill-prepared for the complexities of clinical settings.

In contrast, augmented reality (AR) technology presents new possibilities for nursing education. AR can create highly simulated clinical environments where learners can safely practice complex clinical skills, enhancing clinical decision-making abilities. The implementation of AR-based training programs provides nursing staff with a more realistic and effective learning experience, allowing them to better address the challenges posed by MFWs and ultimately contributing to improvements in patient care and quality of life.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Age range

20 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MacKay Memorial Hosital

New Taipei City, 251404, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Full-time nursing staff working in oncology wards at a teaching hospital in northern Taiwan
  • Individuals willing to participate in the study and who have signed the informed consent form

Exclusion criteria

  • Nursing staff not assigned to oncology-related wards
  • Individuals expected to be unable to complete full participation in the study

Treatment and study plan

MFWs with AR

Other

MFWs with AR This study utilized MyWeb AR as the primary development platform to create an AR-enhanced teaching curriculum for malignant fungating wound (MFW) care. Based on the 2022 Clinical Care Guidelines for Malignant Fungating Wounds and expert input from oncology specialists, the content covers key aspects of MFW care, including wound assessment, symptom identification, and care principles such as odor control, exudate management, and infection prevention. The program uses 3D object elements and animations to create interactive AR scenarios, allowing participants to engage in simulated clinical decision-making and care management, thereby enhancing their skills in a safe and controlled environment.

Classroom Teaching

Other

Classroom Teaching and Case Sharing Introduction to Updated MFWs Care Guidelines and Clinical Applications MFWs Wound Care Management of Common MFWs-Related Complications Case Sharing on MFWs Complication Management: Researchers

Primary outcomes

  1. MFWs care Knowledge scale

    Time frame: 6months

    • **MFWs Care Knowledge Scale** This study will assess MFWs care knowledge using the **MFWs Care Knowledge Scale**.

    The scale ranges from **0 to 100**, with higher scores indicating **better** knowledge levels.

    The assessment will be conducted at **baseline and post-intervention** to measure changes in MFWs care knowledge over time.

Secondary outcomes

  1. Clinical Reasoning Scale

    Time frame: 6months

    This study will assess clinical reasoning ability using the Clinical Reasoning Scale. The scale ranges from 16 to 80, with higher scores representing better clinical reasoning ability. Measurements will be taken before and after the intervention to assess changes in clinical reasoning performance.

Sponsors and collaborators

Lead sponsor

Mackay Memorial Hospital

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Mar 28, 2025
Registry last updated
Dec 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.